Embolic Protection Devices Market Report 2025

This Embolic Protection Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The embolic protection devices market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing demand for advanced interventional techniques, a rise in the geriatric population, growth in healthcare infrastructure, increasing investment in research and development, and growth in clinical trials.

The embolic protection devices market size is expected to see strong growth in the next few years. It will grow to $1.7 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to expanding applications in various vascular procedures, the growing number of complex cardiovascular procedures, the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and rising awareness about embolic risks. Major trends in the forecast period include technological advancements, digital health technologies, personalized medicine, bioresorbable materials, and next-generation filter technologies.

The rising incidence of cardiovascular disorders is expected to drive the growth of the embolic protection devices market. Cardiovascular disorders, including conditions such as heart attacks, strokes, and hypertension, affect the heart and blood vessels, disrupting blood circulation and leading to various health issues. Urbanization often brings lifestyle changes, including reduced physical activity, increased pollution, and higher consumption of unhealthy foods. Additionally, poor dietary habits and high obesity rates contribute significantly to the rise in cardiovascular problems. Embolic protection devices are designed to capture and remove debris that could obstruct blood flow during cardiovascular procedures, minimizing the risk of complications like strokes and improving the safety and efficacy of interventions. For example, in June 2023, the European Environment Agency reported that over 6 million new cases of cardiovascular diseases (CVD) were diagnosed in the EU, with more than 1.7 million people dying from circulatory system diseases in 2022. These deaths accounted for approximately 37% of all fatalities in the region that year. Therefore, the increasing prevalence of cardiovascular disorders is driving the growth of the embolic protection device market.

Leading companies in the embolic protection devices market are concentrating on the development of advanced technologies, such as 3-in-1 carotid stenting systems, to enhance patient outcomes by improving the efficiency and safety of procedures, minimizing complications, and providing more comprehensive protection during carotid artery interventions. The 3-in-1 carotid stenting system is a medical device that combines embolic protection, stenting, and balloon angioplasty into a single solution, designed to increase the safety and effectiveness of carotid artery stenting procedures. For example, in October 2024, Contego Medical, a U.S.-based company specializing in embolic protection devices for cardiovascular and peripheral vascular procedures, received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its Neuroguard IEP System. This advanced 3-in-1 carotid stenting system integrates a high-performance stent, dilation balloon, and embolic filter, simplifying the procedure and improving safety by effectively capturing embolic particles that other traditional protection systems might miss.

In August 2022, Boston Scientific Corporation, a US-based medical technology company, acquired Obsidio Inc. for an undisclosed amount. This acquisition reflects Boston Scientific's dedication to enhancing its interventional oncology and embolization portfolio by integrating GEM technology, which improves procedural efficiency and customization for embolization treatments. Obsidio Inc. is a US-based medical device company specializing in innovative embolic products for vascular embolotherapy.

Major companies operating in the embolic protection devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc., Cook Medical LLC, LivaNova PLC, Cordis Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Endologix LLC, Claret Medical Inc., Cardiovascular Systems Inc., Silk Road Medical Inc., CeloNova Biosciences Inc., Veryan Medical Ltd., Emboline Inc., Keystone Heart Ltd., InspireMD Inc., Innovative Cardiovascular Solutions LLC, Allium Medical Solutions Ltd., Contego Medical LLC, AngioSlide Ltd., Transverse Medical Inc.

North America was the largest region in the embolic protection devices market in 2024. The regions covered in the embolic protection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the embolic protection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Embolic protection devices are specialized medical tools designed to capture and remove embolic debris that might be dislodged during cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR) or carotid artery stenting. These devices are essential for preventing strokes and other complications by trapping debris before it reaches critical organs.

The main types of embolic protection devices include distal filter devices, distal occlusion devices, and proximal occlusion devices. Distal filter devices are specifically designed to catch and remove embolic particles that could travel downstream during procedures, thereby preventing blockages in smaller blood vessels. These devices are used in the treatment of cardiovascular disease, neurovascular disease, and peripheral disease. They are employed by hospitals, ambulatory surgical centers, and other medical facilities.

The embolic protection devices market research report is one of a series of new reports that provides embolic protection devices market statistics, including embolic protection devices industry global market size, regional shares, competitors with a embolic protection devices market share, detailed embolic protection devices market segments, market trends and opportunities, and any further data you may need to thrive in the embolic protection devices industry. This embolic protection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The embolic protection devices market consists of sales of filter devices, diaphragm protection devices, and guidewire-based devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.